02/28/2011 - 9:39am

CVS/pharmacy has announced the launch of the 2011 To Your Health program, offering free preventive health screenings at more than 800 events in communities across the country. The program is designed to help Americans determine their risk for chronic diseases and get them on a path to better health.

02/25/2011 - 2:34pm

Advances in kidney care have not led to successful efforts to improve therapy for patients with Type 1 diabetes, according to a study published in the Journal of the American Society of Nephrology.

02/25/2011 - 10:55am

Over the years, a fatty liver has become an indicator of obesity and insulin resistance among humans, but researchers have found that people with fatty livers are five times more likely to develop Type 2 diabetes than their healthier counterparts.

02/24/2011 - 10:28am

Weis Markets streamlined its internal connection between wellness and pharmacy earlier this year with an organizational restructure that folded the Weis Lifestyle Initiatives department, led by registered dietitian Karen Buch, into the grocer’s pharmacy division.

02/23/2011 - 12:51pm

A convenient blood-glucose test commonly used to diagnose diabetes and prediabetes may not be the best way to diagnose children, according to a new study.

02/23/2011 - 12:04pm

The makers behind a popular Type 2 diabetes treatment have included data from two clinical studies in an update to the drug's prescribing information.

02/22/2011 - 3:33pm

In line with American Heart Month, Boehringer Ingelheim's Micardis has introduced a cardiovascular risk-reduction calculator, designed to assess patients' cardiovascular risk.

02/18/2011 - 10:50am

CVS Caremark announced on Friday that the Pharmacy Benefit Management Institute awarded the company and its PBM client, ArcelorMittal, the 2011 Rx Benefit Innovation Award. The award recognizes the Pharmacy Advisor program, which was developed by CVS Caremark to manage costs, improve medication adherence and close gaps in care for members with diabetes.

02/18/2011 - 10:44am

A drug used to treat high cholesterol, which will lose patent protection and face generic competition starting this year, also may help prevent blindness in people with diabetes, according to a study by researchers at the University of Georgia.